title: Comparison of intraocular pressure in glaucoma subjects treated with Xalatan versus generic latanoprost.
authors.affiliation: Department of Ophthalmology, Indiana School of Medicine, Indianapolis, Indiana, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Egan
authors.forename: Alon
authors.initials: A
authors.lastname: Harris
authors.forename: Brent
authors.initials: B
authors.lastname: Siesky
authors.forename: Leslie
authors.initials: L
authors.lastname: Abrams-Tobe
authors.forename: Austin L
authors.initials: AL
authors.lastname: Gerber
authors.forename: Joshua
authors.initials: J
authors.lastname: Park
authors.forename: Steven
authors.initials: S
authors.lastname: Holland
authors.forename: Nathaniel J
authors.initials: NJ
authors.lastname: Kim
authors.forename: Ingrida
authors.initials: I
authors.lastname: Januleviciene
mesh_terms: D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D016568:Drugs, Generic; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D000077338:Latanoprost; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010865:Pilot Projects; D011446:Prospective Studies; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D013810:Therapeutic Equivalency; D014065:Tonometry, Ocular
chemical_list: D000959:Antihypertensive Agents; D016568:Drugs, Generic; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost